Candida auris, Surveillance, Qualitative PCR, Axilla/Groin

CPT: 87481
Print Share

Synonyms

  • C. auris colonization screening

Expected Turnaround Time

2 - 3 days


Related Documents


Specimen Requirements


Specimen

Composite axilla and groin swab


Volume

One composite swab submitted in Liquid Amies (ESwab®)


Container

Liquid Amies Media (ESwab®)


Collection

A single swab is used to collect a combined (composite) sample from both the left and right axilla and the left and right groin. While collecting the sample, roll the swab tip over the skin several times to ensure adequate specimen collection. Place the swab into the ESwab® collection tube (containing Liquid Amies media) and submit promptly to the laboratory.


Storage Instructions

Refrigerate.


Stability Requirements

Temperature

Period

Refrigerated

14 days

Frozen

30 days

Freeze/thaw cycles

Stable x2


Causes for Rejection

Improperly submitted specimens (specimen submitted without a swab; specimen not submitted using an ESwab® collection device; specimen with a clinical source other than axilla/groin; grossly leaking specimens; specimens received outside of stated stability or without required patient identifiers)


Test Details


Use

This test is used to detect Candida auris colonization of the axilla and groin.


Limitations

A negative test does not rule out colonization with C. auris. Although the axilla and groin are the most common sites of C. auris colonization, other body sites may also be colonized. Results should be interpreted in conjunction with clinical findings and epidemiological risk for C. auris colonization.

Improperly collected samples may result in false negative results.

This test is intended for screening purposes only. It should not be used to diagnose C. auris infection.

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.


Methodology

Polymerase Chain Reaction (PCR)


References

Hata DJ, Humphries R, Lockhart SR; College of American Pathologists Microbiology Committee. Candida auris: An Emerging Yeast Pathogen Posing Distinct Challenges for Laboratory Diagnostics, Treatment, and Infection Prevention. Arch Pathol Lab Med. 2020 Jan;144(1):107-114.31169997
Screening for Candida auris in healthcare settings. Centers for Disease Control and Prevention (CDC) website: www.cdc.gov/fungal/candida-auris/c-auris-screening.html. Updated February 2024. Accessed March 2024.

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
140092 C auris PCR, Axilla/Groin Swab 95765-4 140093 C. auris DNA 95765-4

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf